Breaking News, Promotions & Moves

Executive Moves at Frontage

Represents the next step in the ongoing expansion of Frontage Laboratories to a global platform with increased presence in key markets.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Frontage Holdings Corp., a CRO providing science-driven R&D services with presence in both North America and China, has made several organizational changes and senior staff additions at its wholly owned subsidiary Frontage Laboratories, Inc.   Dr. Song Li has been appointed as chairman and CEO of Frontage Holdings, while continuing in his role as CEO of Frontage Labs. Dr. Li is Frontage’s founder and has been responsible for leading its strategic, technical and commercial success.  I...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters